Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.
D000818:Animals; D001483:Base Sequence; D002645:Chickens; D003001:Cloning, Molecular; D004247:DNA / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D017931:DNA Primers; D019281:Dimerization; D004926:Escherichia coli / Q000235:genetics; D006801:Humans; D020672:I-kappa B Proteins / Q000378:metabolism*; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism*; D020572:Oncogene Proteins v-rel / Q000235:genetics*; D020569:Proto-Oncogene Proteins c-rel / Q000235:genetics*; D011994:Recombinant Proteins / Q000378:metabolism; D012689:Sequence Homology, Nucleic Acid
D017931:DNA Primers; D020672:I-kappa B Proteins; D016328:NF-kappa B; C000606204:NFKBIA protein, human; D020572:Oncogene Proteins v-rel; D020569:Proto-Oncogene Proteins c-rel; D011994:Recombinant Proteins; D000072000:NF-KappaB Inhibitor alpha; D004247:DNA